Advertisements

Immune Pharmaceuticals Inc. (IMNP) Stock Quote

Detailed Quote for Immune Pharmaceuticals Inc. (IMNP)
$ 0.9302 r      -0.0148 (-1.57%) Volume: 1.1m 4:00 PM EDT Oct 20, 2017
After Hours:  $ 0.92   -0.0102 (-1.10%) Volume: 10k 4:27 PM EDT Oct 20, 2017
Today 5d 1m 3m 1y more
Last Price
0.9302
Change $
0.0148
Change %
1.57%
Tick
  
Bid
0.70
Bid Size
2,000
Ask
1.99
Ask Size
500
Open
0.983
High
0.985
Low
0.91
Prev Close
0.945
Last Trade
10/20/17
Volume
1.1m
52 Wk Hi
7.14799976
52 Wk Low
0.879999995
Market Cap
9.84m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
10,575,476
EPS (TTM)
-4.51000022
PE Ratio
N/A
Exchange
NCM
News and Media for Immune Pharmaceuticals Inc. (IMNP)
Sector News | Topic News
News for Immune Pharmaceuticals Inc. (IMNP)
Fri, Oct 20, 2017
8:10 AM Today's Research Reports on Stocks to Watch: Corbus Pharmaceuticals and Immune Pharmaceuticals - ACCESSWIRE IA
Thu, Oct 19, 2017
12:40 PM Midday Gainers / Losers - SeekingAlpha
9:17 AM Immune Pharma prices equity offering; shares down 7% premarket - SeekingAlpha
9:00 AM Immune Pharmaceuticals Inc. Announces Pricing of $18,000,000 Public Offering of Convertible Preferred Stock and Warrants - Business Wire
Wed, Oct 11, 2017
1:00 PM NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on October 11, 2017 - NetworkNewsWire
8:45 AM Immune Pharmaceuticals Announces Presentation at The Liver Meeting 2017 - Business Wire
Fri, Oct 06, 2017
8:10 AM Immune Exits Oncology and Narrows Its Focus on Two Promising Drugs - ACCESSWIRE IA
Thu, Sep 28, 2017
8:20 AM Today's Research Reports on Stocks to Watch: Therapix Biosciences and Immune Pharmaceuticals - ACCESSWIRE IA
6:06 AM Your Daily Pharma Scoop: Celgene's CELMoD Potential, Allergan's Senate Troubles, Abbott Approval Surge - SeekingAlpha
Wed, Sep 27, 2017
1:00 PM NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on September 27, 2017 - NetworkNewsWire
12:45 PM Midday Gainers / Losers - SeekingAlpha
9:26 AM Premarket Gainers as of 9:05 am - SeekingAlpha
9:25 AM Immune Pharma's bertilimumab shows treatment effect in mid-stage bullous pemphigoid study; shares up 53% premarket - SeekingAlpha
8:00 AM Immune Pharmaceuticals Announces Positive Results from Ongoing Phase 2 Trial of Bertilimumab in Bullous Pemphigoid - Business Wire
Thu, Aug 31, 2017
12:41 PM Midday Gainers / Losers - SeekingAlpha
Wed, Aug 30, 2017
12:45 PM Midday Gainers / Losers - SeekingAlpha
Tue, Aug 29, 2017
4:15 PM Immune Pharmaceuticals Receives NASDAQ Letter - Business Wire
Mon, Aug 28, 2017
8:00 AM Immune Pharmaceuticals Provides R&D and Business Update and Summary of Recent Financial Highlights - Business Wire
Fri, Aug 25, 2017
12:45 PM Midday Gainers / Losers - SeekingAlpha
Thu, Aug 24, 2017
12:40 PM Midday Gainers / Losers - SeekingAlpha
More News for IMNP >>

Tags for Immune Pharmaceuticals Inc.

Research stocks or mutual funds related to Immune Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to IMNP. The keywords below have been associated to IMNP by either user submission or electronic means.